New drug to treat depression comes with fewer sexual side effects.
Another antidepressant will hit store shelves sometime this year which, in studies, was said to have fewer reported incidents of sexual side effects.
And that's a major issue for people who take drugs for anxiety and depression. Dr. Darren Tate is an OB-GYN, but he sees patients everyday who are struggling with depression.
Dr. Darren Tate, OB-GYN, says "a lot of our patients come to their gynecologist as their sole provider, particularly when they're having menopausal issues or depression issues."
So, he often prescribes antidepressants, which frequently leads to another complaint: Decreased libido. It's one of the reasons patients often choose to stop taking those medications.
Dr. Tate says "decreased libido and decreased sexual function in the studies is up to 40 percent, but I think we see more of that, honestly, I think that's underreported."
A new option for those patients is expected to hit the market this year. In January, the FDA approved Vilazodone HCL tablets to be marketed under the brand name Vibryd, for the treatment of adults with major depressive disorder.
Dr. Tate says drug company reps have been stopping by his office and patients are already asking about it.
Dr. Tate says "like a lot of doctors, I'm a little cautious on giving new medications, but what I'm reading is encouraging because it is in the SSRI category which we know these are safe drugs so I think we will be using this very soon with our patients."
Vibryd was originally slated to be released in the second quarter, but the company is being sold so customers may not be able to get it in drug stores until later in the year.
And, as always, doctors warn that no one therapy works for everyone. And side effects vary from person to person.